How does proprietary membrane protein expression technology support drug discovery?

Discovery Biology Services

}

Home / CRO Services / Discovery Biology Services / Discovery Biology Services detail

Time: 2026-07-14

Source: Viva Biotech

[Abstract]:

Viva Biotech’s proprietary membrane protein expression technology enables the successful production of challenging targets such as GPCRs and ion channels. Our platform combines optimized expression hosts, stabilizing fusion partners and mutations, detergent/nanodisc reconstitution, and conformation-locking strategies (e.g., nanobody co-complexing) to generate homogeneous, functionally active protein. This directly enables downstream applications — high-quality structure determination, SPR and other biophysical assays.

We have a membrane protein library covering 120+ GPCRs, 80+ transporters, and 50+ channels.

Previous Page：None... Next Page：Can the expressed protein be used directly for crystallography or Cryo-EM at Viva Biotech?

Back

Media contact: vivapr@vivabiotech.com